Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
- Iborra, M.
- Beltrán, B.
- Maroto, N.
- Navarro-Cortés, P.
- Boscá-Watts, M.
- Ferrer-Bradley, I.
- García-Morales, N.
- Sáez-González, E.
- Hinojosa, J.
- Mínguez, M.
- Nos, P.
ISSN: 1578-9519, 0210-5705
Year of publication: 2018
Volume: 41
Issue: 9
Pages: 535-543
Type: Article